Skip to content

Home
About Us
Office
E-Library
Research Support
Blog
Donation
Contact Us

Home
About Us
Office
E-Library
Research Support
Blog
Donation
Contact Us

Uncategorized

New Releases from NCBI BookshelfPemigatinib for treating relapsed or refractor advanced cholangiocarcinoma with FGFR2 fusion or rearrangement.Pemigatinib for treating relapsed or refractor advanced cholangiocarcinoma with FGFR2 fusion or rearrangement.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfAbemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy.Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfAbiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer.Abiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfVericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal).Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal).

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfDaratumumab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal).Daratumumab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal).

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfMidostaurin for treating advanced systemic mastocytosis.Midostaurin for treating advanced systemic mastocytosis.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfNivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancer.Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancer.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfBimekizumab for treating moderate to severe plaque psoriasis.Bimekizumab for treating moderate to severe plaque psoriasis.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfClassification of Cancer Cachexia: A Systematic Review.Classification of Cancer Cachexia: A Systematic Review.

Leave a Comment / Uncategorized / admin

Cachexia is a progressive wasting syndrome characterized by loss of weight and muscle mass, and changes in inflammatory and metabolic

New Releases from NCBI BookshelfThe quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review [Internet].The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review [Internet].

Leave a Comment / Uncategorized / admin

Glucagon-like peptide 1 receptor agonists are a class of drug originally developed to treat type 2 diabetes but now increasingly

← Previous 1 … 77 78 79 … 232 Next →

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

Registration No: 771800548 Contact Number : +91-8249516996

Publication
Skill Development
Blog Writing

Research
Awareness Camp
Digital Research

Ngo Darpan
Service
Donation

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.

Term and Condition
Privacy Policy
Disclaimer

Scroll to Top